Tag: 501Y.V2
Man in France critical after coronavirus reinfection with South African variant 501Y.V2
Doctors in France are treating a critically ill patient infected with the South African coronavirus variant, four months after he recovered from Covid-19, in what study authors said was the first case of its kind. More...
Circulating SARS-CoV-2 variants B.1.1.7, 501Y.V2, and P.1 have gained ability to utilize rat and mouse Ace2 and altered in vitro sensitivity to neutralizing antibodies and ACE2-Ig
Here, we first investigated cross-species receptor usage of multiple SARS-CoV-2 variants that emerged during the pandemic. More...
SARS-CoV-2 501YV2 escapes neutralization by South African COVID-19 donor plasma
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
“SARS-CoV-2 501Y.V2, More...
Moderna developing vaccine “booster shot” against 501YV2 variant
Moderna said its Covid-19 vaccine appeared to protect against emerging variants of the coronavirus in laboratory tests, but as a precaution it would test whether a booster shot improves immune responses and develop a new vaccine targeting the strain first identified in South Africa. More...
Major outbreak of SARS-CoV-2 South African Variant 501YV2 in Ostend, Belgium
Belgium has declared its first major outbreak of the South African variant of the virus that causes Covid-19 [501Y.V2], More...
Study of convalescent sera from 44 South Africans infected in first wave, >90% showed reduced immunity & 48% had complete immune escape to 501Y.V2
Study of convalescent sera from 44 South Africans infected in first wave >90% showed reduced immunity and 48% had complete immune esape to 501Y.V2 More...
Scientists discuss the new South African SARS-CoV-2 variant 501Y.V2
Scientists have new biological evidence that a South African variant of Covid-19 binds more readily to human cells, making it more infectious, according to one of the world’s leading infectious disease experts. More...